4//SEC Filing
Mutz Christopher 4
Accession 0001846487-25-000002
CIK 0001023024other
Filed
Feb 17, 7:00 PM ET
Accepted
Feb 18, 8:17 PM ET
Size
10.0 KB
Accession
0001846487-25-000002
Insider Transaction Report
Form 4
Mutz Christopher
HEAD OF RARE DISEASE
Transactions
- Tax Payment
Common Stock
2025-02-15$58.92/sh−1,184$69,761→ 115,466 total - Award
Common Stock
2025-02-12+16,538→ 118,123 total - Tax Payment
Common Stock
2025-02-14$58.92/sh−1,473$86,789→ 116,650 total - Award
Common Stock
2025-02-12+24,808→ 101,585 total
Footnotes (4)
- [F1]Represents a restricted stock award that will vest in four equal annual installments on the first, second, third and fourth anniversaries of February 12, 2025.
- [F2]These shares represent performance stock units, which will vest over the applicable performance period based on the achievement of the provided performance targets, as set forth in the governing award agreement, subject to the reporting person's continued service as of the applicable vesting date and that will be settled into common stock upon vesting.
- [F3]Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 4,697 shares of restricted stock, the grant of which was previously reported.
- [F4]Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 4,034 shares of restricted stock, the grant of which was previously reported.
Documents
Issuer
ANI PHARMACEUTICALS INC
CIK 0001023024
Entity typeother
Related Parties
1- filerCIK 0001846487
Filing Metadata
- Form type
- 4
- Filed
- Feb 17, 7:00 PM ET
- Accepted
- Feb 18, 8:17 PM ET
- Size
- 10.0 KB